Stocks
Intercept Pharmaceuticals (ICPT) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -10.1 | -12.9 | -4.30 | -18.3 | 2.56 | -19.9 | ||
| Changes by years, y/y, % | -5 723% | +28% | -67% | +325% | -114% | +70.3% | |||
Intercept Pharmaceuticals. EV/EBITDA
Intercept Pharmaceuticals. EV/EBITDA, changes, %
Intercept Pharmaceuticals (ICPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | FY2023Q3 | LTM ? | |||
| EV/EBITDA | ? | -5.95 | 3.34 | -7.22 | -7.95 | 2.82 | -19.9 | |
| Changes by years, y/y, % | -46% | -120% | -83% | -61% | -147% | |||
| Changes by quarters, q/q, % | -71% | -156% | -316% | +10% | -136% | |||
